Polymer coating of porcine decellularized and cross-linked aortic grafts

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 94, Issue 1, 2010, Pages 256-263

  Heidenhain, Christoph ^a   Weichert, Wilko ^a   Schmidmaier, Gerhard ^a   Wildemann, Britt ^a   Hein, Moritz ^a   Neuhaus, Peter ^a   Heise, Michael ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Regenerative medicine; Scaffolds; Thrombogenecity; Vascular graft; Vascular prosthesis

Indexed keywords

ANTI-COAGULANT DRUGS; BIOIMPLANTS; DECELLULARIZED; NEOINTIMAL HYPERPLASIA; PATENCY RATES; POLY(D ,L-LACTIDE); POLYMER COATING; PORCINE MODELS; REGENERATIVE MEDICINE; REPOPULATION; THROMBOGENECITY; THROMBOGENESIS; VASCULAR GRAFTS; VASCULAR PROSTHESIS;

BIOCOMPATIBILITY; BLOOD VESSEL PROSTHESES; BLOOD VESSELS; CONTROLLED DRUG DELIVERY; GRAFTS; SCAFFOLDS;

PLASTIC COATINGS;

LEPIRUDIN; POLYLACTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; AORTA GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; BIOCOMPATIBILITY; BLOOD VESSEL PROSTHESIS; CELL POPULATION; CONTROLLED STUDY; CROSS LINKING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MATERIAL COATING; MINIPIG; NONHUMAN; REGENERATIVE MEDICINE; STATISTICAL SIGNIFICANCE; THROMBOGENESIS; VASCULAR PATENCY;

ANIMALS; ANTICOAGULANTS; AORTA; BLOOD VESSEL PROSTHESIS; COATED MATERIALS, BIOCOMPATIBLE; CROSS-LINKING REAGENTS; FEMALE; HIRUDINS; HUMANS; MATERIALS TESTING; POLYMERS; PROSTHESIS DESIGN; RECOMBINANT PROTEINS; SUS SCROFA;

EID: 77954130557     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31650     Document Type: Article

References (28)

1. Schmitt DD, Seabrook GR, Bandyk DF, Towne JB. Graft excision and extra-anatomic revascularization: The treatment of choice for the septic aortic prosthesis. J Cardiovasc Surg (Torino) 1990;31:327-332.
2. Seeger JM, Pretus HA, Welborn MB, Ozaki CK, Flynn TC, Huber TS. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg 2000;32:451-459.
3. Kieffer E, Gomes D, Chiche L, Fleron MH, Koskas F, Bahnini A. Allograft replacement for infrarenal aortic graft infection: Early and late results in 179 patients. J Vasc Surg 2004;39:1009-1017. (Pubitemid 38581631)
4. Sarkar S, Schmitz-Rixen T, Hamilton G, Seifalian AM. Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: A review. Med Biol Eng Comput 2007;45:327-336. (Pubitemid 46510857)
5. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials 2006;27:3675-3683.
6. Wang Z, Wang S, Marois Y, Guidoin R, Zhang Z. Evaluation of biodegradable synthetic scaffold coated on arterial prostheses implanted in rat subcutaneous tissue. Biomaterials 2005;26:7387-7401. (Pubitemid 41133590)
7. Courtman DW, Errett BF, Wilson GJ. The role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices. J Biomed Mater Res 2001;55:576-586.
8. Rieder E, Nigisch A, Dekan B, Kasimir MT, Mühlbacher F, Wolner E, Simon P, Weigel G. Granulocyte-based immune response against decellularized or glutaraldehyde cross-linked vascular tissue. Biomaterials 2006;27:5634-5642. (Pubitemid 44279060)
9. Schmidt CE, Baier JM. Acellular vascular tissues: Natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000;21:2215-2231.
10. Liang HC, Chang Y, Hsu CK, Lee MH, Sung HW. Effects of cross-linking degree of an acellular biological tissue on its tissue regeneration pattern. Biomaterials 2004;25:3541-3552. (Pubitemid 38327043)
11. Huang LL, Sung HW, Tsai CC, Huang DM. Biocompatibility study of a biological tissue fixed with a naturally occurring cross-linking reagent. J Biomed Mater Res 1998;42:568-576.
12. Sung HW, Huang RN, Huang LL, Tsai CC. In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. J Biomater Sci Polym Ed 1999;10:63-78.
13. Chang Y, Tsai CC, Liang HC, Sung HW. In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials 2002;23:2447-2457.
14. Chang Y, Hsu CK, Wei HJ, Chen SC, Liang HC, Lai PH, Sung HW. Cell-free xenogenic vascular grafts fixed with glutaraldehyde or genipin: In vitro and in vivo studies. J Biotechnol 2005;120:207-219.
15. Schmidmaier G, Lucke M, Schwabe P, Raschke M, Haas NP, Wildemann B. Collective review: Bioactive implants coated with poly (D,L-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing. J Long Term Eff Med Implants 2006;16:61-69.
16. Tamada JA, Langer R. Erosion kinetics of hydrolytically degradable polymers. Proc Natl Acad Sci USA 1993;90:552-556. (Pubitemid 23028901)
17. Schmidmaier G, Wildemann B, Lübberstedt M, Haas NP, Raschke M. IGF-I and TGF-beta 1 incorporated in a poly(D,L-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture. J Biomed Mater Res B Appl Biomater 2003;65:157-162.
18. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M. Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res 2001;58:449-455.
19. Tasş C, Kozluca A, Onur MA, Tümer A, Vahapoǧlu H, Zareie MH, Gunning PA, Pisşkin E. In vivo degradation and release kinetics of chloramphenicol-loaded poly(D,L)-lactide sponges. Tissue Eng 1998;4:353-363.
20. Heise M, Schmidmaier G, Husmann I, Heidenhain C, Schmidt J, Neuhaus P, Settmacher U. PEG-hirudin/iloprost coating of small diameter ePTFE grafts effectively prevents pseudointima and intimal hyperplasia development. Eur J Vasc Endovasc Surg 2006;32:418-424.
21. Herrmann R, Schmidmaier G, Märkl B, Resch A, Hähnel I, Stemberger A, Alt E. Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb Haemost 1999;82:51-57.
22. Alt E, Seliger C. Antithrombotic stent coatings: Hirudin/iloprost combination. Semin Interv Cardiol 1998;3:177-183.
23. Ducasse E, Fleurisse L, Vernier G, Speziale F, Fiorani P, Puppinck P, Creusy C. Interposition vein cuff and intimal hyperplasia: An experimental study. Eur J Vasc Endovasc Surg 2004;27:617-621.
24. Kissin M, Kansal N, Pappas PJ, Defouw DO, Durán WN, Hobson RW. Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts. J Vasc Surg 2000;31 (Part 1):69-83. (Pubitemid 30067304)
25. Karges HE, Funk KA, Ronneberger H. Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung 1994;44:793-797. (Pubitemid 24210117)
26. Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Ingham E, Fisher J. In-vitro assessment of the functional performance of the decellularized intact porcine aortic root. J Heart Valve Dis 2005;14:408-421. (Pubitemid 47050756)
27. Grauss RW, Hazekamp MG, Van Vliet S, Gittenberger-De Groot AC, Deruiter MC. Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling. J Thorac Cardiovasc Surg 2003;126:2003-2010. (Pubitemid 38020765)
28. Courtman DW, Pereira CA, Kashef V, Mccomb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994;28:655-666. (Pubitemid 24148315)